BETHLEHEM, Pa., QUEENSLAND, Australia and BEIJING, May 9, 2011
/PRNewswire/ — Saladax Biomedical, Inc., a privately held company
developing and commercializing novel diagnostic assays to achieve
the promise of personalized medicine for new and existing
therapeutics, announced today the formation of its Pacific Rim
commercialization team to expand its presence in Australia and
China.
Members of Saladax’s Pacific Rim commercialization team
include:
- Yunying Li, Ph.D. (Saladax Biomedical, Inc.) – Dr.
Li, Director of Market Development, Asia, with Saladax Biomedical,
has held leadership roles in the Company since 2004. Until
2010, she served as Research Group Leader, supervising product
development efforts of the MyCare™ assay development group.
Prior to Saladax, Dr. Li was a senior research scientist at
OraSure Technologies, Inc. Dr. Li has relocated to Beijing
where, utilizing her technical experience with the MyCare line and
her cultural ties in China, she will lead the establishment of
Saladax’s commercial presence in this important market.
- Patrick Cook (Macarthur Cook Group Pty Ltd) – Mr.
Cook is Principal at Macarthur Cook Group Pty Ltd, a privately held
company in Queensland, Australia, which provides business
development, education and training services. Mr. Cook’s
extensive experience in the Australian diagnostic industry will
help Saladax expand its sales and marketing efforts in Australia.
Mr. Cook serves as director and board member of IVD Australia
Ltd., a leader in Australia’s in vitro diagnostic industry.
He has worked with multiple international and local
organizations including Roche Diagnostics, Quidel, Abbott
Diagnostics and Royal Brisbane & Women’s Hospital.
“With Dr. Li’s extensive experience working with Saladax and Mr.
Cook’s significant know
‘/>”/>
